chr22-46242314-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005036.6(PPARA):​c.*6934G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.099 in 152,620 control chromosomes in the GnomAD database, including 818 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.099 ( 815 hom., cov: 32)
Exomes 𝑓: 0.095 ( 3 hom. )

Consequence

PPARA
NM_005036.6 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.00

Publications

6 publications found
Variant links:
Genes affected
PPARA (HGNC:9232): (peroxisome proliferator activated receptor alpha) Peroxisome proliferators include hypolipidemic drugs, herbicides, leukotriene antagonists, and plasticizers; this term arises because they induce an increase in the size and number of peroxisomes. Peroxisomes are subcellular organelles found in plants and animals that contain enzymes for respiration and for cholesterol and lipid metabolism. The action of peroxisome proliferators is thought to be mediated via specific receptors, called PPARs, which belong to the steroid hormone receptor superfamily. PPARs affect the expression of target genes involved in cell proliferation, cell differentiation and in immune and inflammation responses. Three closely related subtypes (alpha, beta/delta, and gamma) have been identified. This gene encodes the subtype PPAR-alpha, which is a nuclear transcription factor. Multiple alternatively spliced transcript variants have been described for this gene, although the full-length nature of only two has been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.11 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005036.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPARA
NM_005036.6
MANE Select
c.*6934G>A
3_prime_UTR
Exon 9 of 9NP_005027.2
PPARA
NM_001001928.4
c.*6934G>A
3_prime_UTR
Exon 8 of 8NP_001001928.1Q07869-1
PPARA
NM_001001929.3
c.*6934G>A
3_prime_UTR
Exon 7 of 7NP_001001929.1Q07869-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPARA
ENST00000407236.6
TSL:1 MANE Select
c.*6934G>A
3_prime_UTR
Exon 9 of 9ENSP00000385523.1Q07869-1

Frequencies

GnomAD3 genomes
AF:
0.0989
AC:
15045
AN:
152060
Hom.:
814
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0993
Gnomad AMI
AF:
0.176
Gnomad AMR
AF:
0.0886
Gnomad ASJ
AF:
0.130
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.0556
Gnomad FIN
AF:
0.0759
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.113
Gnomad OTH
AF:
0.0990
GnomAD4 exome
AF:
0.0950
AC:
42
AN:
442
Hom.:
3
Cov.:
0
AF XY:
0.102
AC XY:
27
AN XY:
266
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.0930
AC:
40
AN:
430
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.167
AC:
1
AN:
6
Other (OTH)
AF:
0.167
AC:
1
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0990
AC:
15061
AN:
152178
Hom.:
815
Cov.:
32
AF XY:
0.0960
AC XY:
7144
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0996
AC:
4133
AN:
41496
American (AMR)
AF:
0.0884
AC:
1352
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.130
AC:
452
AN:
3464
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5184
South Asian (SAS)
AF:
0.0547
AC:
264
AN:
4830
European-Finnish (FIN)
AF:
0.0759
AC:
804
AN:
10596
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.113
AC:
7657
AN:
68002
Other (OTH)
AF:
0.0975
AC:
206
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
686
1372
2057
2743
3429
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.106
Hom.:
814
Bravo
AF:
0.0988
Asia WGS
AF:
0.0280
AC:
99
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
7.6
DANN
Benign
0.59
PhyloP100
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79700435; hg19: chr22-46638211; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.